Product Program year 2020 Source: CMS Open Payments

Olympus Bronchoscopes

Device GI & Respiratory Products

Open in the dashboard

General payments

$1,502,667

1,124 payments

Research payments

$1,549,125

2 payments

Through program year 2020, $1,502,667 in general payments and $1,549,125 in research payments were reported against Olympus Bronchoscopes (GI & Respiratory Products).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2020 General $498,094 196
2019 General $1,004,573 928
2019 Research $1,549,125 2

Breakdown

Who paid General payments · program years 2019–2020
  1. Olympus America Inc. $849,368 269 payments
  2. Olympus Corporation of the Americas $653,299 855 payments
Top recipients General payments · program year 2020
  1. Mount Sinai Hospital Teaching hospital · NY $285,856 57% · 2 payments
  2. Ut Md Anderson Cancer Center Teaching hospital · TX $69,001 14% · 1 payment
  3. Momen Wahidi Pulmonary Disease · Chicago, IL $16,303 3% · 22 payments
  4. The Queens Medical Center Teaching hospital · HI $16,119 3% · 2 payments
  5. Gerard Silvestri Pulmonary Disease · Charleston, SC $14,569 3% · 11 payments

The top 5 of 42 recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Pulmonary Disease Internal Medicine $79,203 81% · 26 practitioners
  2. Internal Medicine $6,952 7% · 2 practitioners
  3. Critical Care Medicine Internal Medicine $4,955 5% · 4 practitioners
  4. Gastroenterology Internal Medicine $4,200 4% · 1 practitioner
  5. Diagnostic Radiology Radiology $2,598 3% · 2 practitioners

The top 5 of 6 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2020
  1. New York $314,611 63% · 5 recipients
  2. Texas $69,537 14% · 3 recipients
  3. South Carolina $18,882 4% · 2 recipients
  4. North Carolina $16,303 3% · 1 recipient
  5. Hawaii $16,119 3% · 1 recipient

The top 5 of 24 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

1,124 general · 2 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record